Tigulixostat

SKU: orb1689402

Description

Tigulixostat (LC350189) is a novel xanthine oxidase inhibitor developed for research into hyperuricemia and gout. It effectively lowers uric acid levels in both cellular and animal models, making it a valuable tool for studying disease mechanisms and potential therapeutic approaches.

Research Area

Metabolism Research

Key Properties

• CAS Number: 1287766-55-5
• MW: 294.31
• Purity: 99.71%
• Formula: C₁₆H₁₄N₄O₂
• SMILES: CC(C)n1cc(C#N)c2cc(ccc12)-n1cc(cn1)C(O)=O
• Target: Xanthine Oxidase
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (11.21 mM);DMSO:80 mg/mL (271.82 mM)

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

XanthineOxidase, Xanthine Oxidase, LC350189

Compound Identifiers

PubChem CID

51039100